Loomis, Sayles & Company’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,387,568
Closed -$28.4M 859
2022
Q3
$28.4M Sell
1,387,568
-13,424
-1% -$295K 0.06% 170
2022
Q2
$27.1M Buy
1,400,992
+134,075
+11% +$2.75M 0.05% 189
2022
Q1
$27.3M Buy
1,266,917
+238,739
+23% +$5.42M 0.04% 243
2021
Q4
$28.4M Buy
1,028,178
+296,312
+40% +$8.18M 0.03% 260
2021
Q3
$19M Buy
+731,866
New +$19.6M 0.02% 310
2019
Q4
Sell
-230,122
Closed -$4.24M 732
2019
Q3
$4.24M Buy
230,122
+158
+0.1% +$3.09K 0.01% 412
2019
Q2
$4.53M Buy
229,964
+63,027
+38% +$1.28M 0.01% 423
2019
Q1
$3.82M Buy
166,937
+5,661
+4% +$123K 0.01% 460
2018
Q4
$3.25M Buy
161,276
+29,840
+23% +$617K 0.01% 451
2018
Q3
$2.86M Sell
131,436
-12,717
-9% -$282K 0.01% 517
2018
Q2
$3.21M Buy
144,153
+143,578
+24,970% +$2.93M 0.01% 536
2018
Q1
$10K Sell
575
-628
-52% -$10.5K ﹤0.01% 802
2017
Q4
$20K Sell
1,203
-593
-33% -$10.1K ﹤0.01% 755
2017
Q3
$31K Sell
1,796
-40
-2% -$672 ﹤0.01% 685
2017
Q2
$30K Buy
1,836
+72
+4% +$1.14K ﹤0.01% 689
2017
Q1
$31K Buy
1,764
+952
+117% +$15.9K ﹤0.01% 690
2016
Q4
$14K Buy
+812
New +$13.5K ﹤0.01% 817

Other funds holding ANGO

Loomis, Sayles & Company's ANGO Position: Q4 2022 in Review

Loomis, Sayles & Company sold out of AngioDynamics (ANGO) in Q4 2022, closing a stake of 1,387,568 shares — an estimated $28.4M sold.

Loomis, Sayles & Company first reported a position in ANGO in Q4 2016 and held it in 17 quarters. The position peaked at $28.4M in Q3 2022. 149 funds tracked by Wall St. Rank hold ANGO as of Q4 2022.

  • Loomis, Sayles & Company reported no remaining AngioDynamics position as of Q4 2022 after selling out during the quarter.
  • Loomis, Sayles & Company sold 1,387,568 AngioDynamics shares in Q4 2022, an estimated $28.4M.
  • Loomis, Sayles & Company first reported a position in AngioDynamics in Q4 2016 and held it in 17 quarters.
  • Loomis, Sayles & Company's AngioDynamics position peaked at $28.4M in Q3 2022.
  • 149 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2022.

Based on Loomis, Sayles & Company's 13F filing for Q4 2022, filed 10 Feb 2023.